DTaP-Hib vaccine is a combination vaccine whose generic name is diphtheria and tetanus toxoids and acellular pertussis adsorbed with Haemophilus B conjugate vaccine, sometimes abbreviated to DTaP-Hib.
[2] It protects against the infectious diseases diphtheria, tetanus, pertussis, and Haemophilus influenzae type B.
[3][4] A branded formulation was marketed in the US as TriHIBit by Sanofi Pasteur, and administered by using the Sanofi DTaP vaccine Tripedia to reconstitute the Sanofi Hib vaccine ActHIB.
[3][5][6] TriHIBit and Tripedia were discontinued in 2011.
You can help Wikipedia by expanding it.